 and Novo Nordisk (NVO) traded lower on the news. Learn more in the video above. To watch more expert insights and analysis on the latest market action, check out more Asking for a Trend here.){kind=link}
The Trump administration has decided not to back a Biden administration plan that would have allowed Medicare to pay for obesity drugs, according to a report from Bloomberg. Shares of both Eli Lilly (LLY) and Novo Nordisk (NVO) traded lower on the news. Learn more in the video above.
To watch more expert insights and analysis on the latest market action, check out more Asking for a Trend here.
Novo Nordisk, The Trump administration, Eli Lilly, Medicare, obesity drugs, Bloomberg
#Trump #admin #reportedly #drop #Medicare #GLP1 #plan